R1 RCM to be acquired by TowerBrook and Clayton, Dubilier & Rice for $8.9 Billion
08/09/24 at 03:00 AM
R1 RCM to be acquired by TowerBrook and Clayton, Dubilier & Rice for $8.9 Billion
Towerbrook press release; 8/1/24
R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice, in an all-cash transaction with an enterprise value of approximately $8.9 billion.
Publisher's note: Both TowerBrook and Clayton, Dubilier & Rice are active in the hospice private equity space.